Genotype-phenotype mapping in human somatic evolution
Dan Landau, Associate Professor of Medicine at Weill Cornell Medicine, a Core Member of the New York Genome Center and member of the Early Cancer Institute Scientific Advisory Board
When: Thursday 6 June, 12:30–14:00 including lunch
Where: CHANGE OF VENUE: Clifford Allbutt Lecture Theatre, Cambridge Biomedical Campus, Cambridge, CB2 0SP
Lunch is provided from 12.30, the talk will begin at 1pm followed by a Q&A. Please ensure you arrive promptly.
Speaker Biography:
Dan Landau, MD, PhD is Associate Professor of Medicine at Weill Cornell Medicine and a Core Member of the New York Genome Center. He is an oncologist whose long-term goal is to develop novel approaches to address cancer evolution as a central obstacle to cure. Dr. Landau has made seminal contributions to our understanding of cancer biology, developing novel genomics approaches to integrate genetic and non-genetic determinants of cancer evolution. He has also pioneered innovative genomics technologies for the study of cancer evolution, including for liquid biopsy treatment monitoring. His research group is funded by the NCI, NHLBI and NHGRI, and his work has led to recognition and awards including Stand Up to Cancer, Burroughs Wellcome Fund, Vallee Scholar, Mark Foundation Emerging Leader Award and the NIH Director’s New Innovator Award.
Please register using the link below
